Opioid agonist therapyOpioid agonist therapy (OAT) is a treatment in which prescribed opioid agonists are given to patients who live with Opioid use disorder (OUD). The benefits of this treatment include a more manageable withdrawal experience, cognitive improvement, and lower HIV transmission. The length of OAT varies from one individual to another based on their physiology, environmental surroundings, and quality of life. The term medication for Opioid Use Disorder (MOUD) is used to describe medication including methadone and buprenorphine, which are used to treat patients with OUD.
MéthadoneLa méthadone est un opioïde analgésique synthétisé en 1937 par les Allemands et de chez I.G. Farben qui cherchaient un analgésique de synthèse qui serait si possible d'un emploi plus aisé au cours d'une intervention chirurgicale et aurait de plus un moindre potentiel d'addiction. La molécule de méthadone a un centre stéreogène – le C6 qui porte 4 substituants différents – induisant une chiralité de la méthadone, elle se présente donc sous forme de deux énantiomères : (R)-méthadone (S)-méthadone qui sont différenciables par leur pouvoir rotatoire opposé.
RashA rash is a change of the human skin that affects its color, appearance, or texture. A rash may be localized in one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, chapped, dry, cracked or blistered, swell, and may be painful. The causes, and therefore treatments for rashes, vary widely. Diagnosis must take into account such things as the appearance of the rash, other symptoms, what the patient may have been exposed to, occupation, and occurrence in family members.